BIIB Jun 2024 350.000 call
OPR - OPR Delayed price. Currency in USD
Add to watchlist
As of 02:15PM EDT. Market open.
| Previous close | 1.5000 |
| Open | 0.1000 |
| Bid | 0.1000 |
| Ask | 4.4000 |
| Strike | 350.00 |
| Expiry date | 2024-06-21 |
| Day's range | 0.1000 - 0.1000 |
| Contract range | N/A |
| Volume | |
| Open interest | 64 |
Simply Wall St.Biogen Inc. (NASDAQ:BIIB) Just Released Its First-Quarter Earnings: Here's What Analysts Think
It's been a good week for Biogen Inc. ( NASDAQ:BIIB ) shareholders, because the company has just released its latest...
ZacksSage Therapeutics (SAGE) Q1 Earnings Miss, Sales Beat Estimates
Sage Therapeutics' (SAGE) first-quarter 2024 results are mixed as earnings miss estimates, but sales beat the mark. The newly-launched depression drug Zurzuvae drives the company's top line.
ZacksThe Zacks Analyst Blog Highlights Biogen, Bristol Myers Squibb, Incyte and Vertex Pharmaceuticals
Biogen, Bristol Myers Squibb, Incyte and Vertex Pharmaceuticals are part of the Zacks top Analyst Blog.
© 2024 Yahoo. All rights reserved.